SEMA3F and glioblastoma: Moreover, Sema3C/Sema3F signaling via NRP2 may regulate lymphoangiogenesis in GBM, as anti-NRP2 treatment significantly reduced lymphatic vessel density in GBM xenografts generated by the injection of rat C6 cells [68].